Altered miR-410-3p and Target Genes (PCDH8, VEGFA, NUMB) Expression in Ovarian Endometriosis: A Case-Control Study

Area of Science:

• Reproductive biology
• Molecular biology
• Genetics

Background:

• Endometriosis is a condition characterized by endometrial-like tissue growth outside the uterus.
• Angiogenesis, the formation of new blood vessels, is a critical factor in endometriosis development.
• Bioinformatics analysis suggests microRNA-410-3p (miR-410-3p) regulates key genes involved in angiogenesis, including Vascular Endothelial Growth Factor A (VEGFA), NUMB endocytic adaptor protein, and Protocadherin 8 (PCDH8).

Purpose of the Study:

• To investigate the expression levels of miR-410-3p, VEGFA, NUMB, and PCDH8 in ovarian endometriosis.
• To determine the potential role of these molecules in the pathogenesis of ovarian endometriosis.

Main Methods:

• Analysis of 48 ectopic and 48 eutopic ovarian tissue samples from endometriosis patients, alongside 48 control samples.
• Quantification of miR-410-3p, VEGFA, NUMB, and PCDH8 expression using real-time quantitative polymerase chain reaction (RT-qPCR).

Main Results:

• miR-410-3p expression was significantly lower in ectopic endometriosis tissues compared to eutopic tissues and controls (p < 0.0001).
• VEGFA and NUMB expression were significantly higher in ectopic endometriosis tissues compared to eutopic tissues and controls (p < 0.001).
• PCDH8 expression was significantly lower in ectopic endometriosis tissues compared to eutopic tissues and controls (p < 0.001).
• No significant differences in gene expression were observed between eutopic tissues and control samples (p > 0.99).

Conclusions:

• The study suggests that dysregulation of miR-410-3p, VEGFA, NUMB, and PCDH8 expression is associated with ovarian endometriosis.
• These molecules may play a role in the development of endometriosis.
• Targeting miR-410-3p and its associated genes could offer potential therapeutic strategies for endometriosis.